Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Interface Biosciences
Interface Bio is a drug discovery company focused on developing next-generation immunotherapies for complex diseases such as autoimmune disorders and cancer. They leverage a proprietary platform that…
Interface Biosciences
Interface Bio is a drug discovery company focused on developing next-generation immunotherapies for complex diseases such as autoimmune disorders and cancer. They leverage a proprietary platform that…
TL;DR
What they do: Microbiome-derived drug discovery using metabolomics, molecular engineering, and AI to develop multi-mechanism immunotherapies
Founded: 2020
Headquarters: Palo Alto, California
Founders / leadership: Hannah C. Wastyk, Ph.D. (Co‑founder & CEO); Will Van Treuren, Ph.D. (Co‑founder & CSO)
Stage / financing: Early-stage, VC-backed (seed reported; amount undisclosed)
Company Overview
Problem Domain
Autoimmune and inflammatory diseases; oncology (complex diseases requiring multi-mechanism therapies).
Founded
2020
Industry
Biotechnology
Tech Stack
Funding Track Record
Public profiles list seed financing with investors including LongeVC and Ulu Ventures; amount undisclosed.
Investor Signal
“LongeVC; Ulu Ventures; additional investors reported (total listed as five)”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,400+
New This Week